An integrated chemical biology approach identifies specific vulnerability of Ewing's sarcoma to combined inhibition of Aurora kinases A and B.
Ewing's sarcoma is a pediatric cancer of the bone that is characterized by the expression of the chimeric transcription factor EWS-FLI1 that confers a highly malignant phenotype and results from the chromosomal translocation t(11;22)(q24;q12). Poor overall survival and pronounced long-term side...
Main Authors: | Winter, G, Rix, U, Lissat, A, Stukalov, A, Müllner, M, Bennett, K, Colinge, J, Nijman, S, Kubicek, S, Kovar, H, Kontny, U, Superti-Furga, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Combinatorial drug screening identifies Ewing sarcoma-specific sensitivities
by: Radic-Sarikas, B, et al.
Published: (2016) -
Localized Ewing sarcoma of the tibia.
by: Kashima, T, et al.
Published: (2013) -
Heterogeneity in Ewing sarcoma
by: Branford White, HA
Published: (2014) -
Targeted treatment of Ewing sarcomas: Current status
by: Hassan, A
Published: (2013) -
Ewing's sarcoma cells promote osteoclast formation
by: Taylor, R, et al.
Published: (2010)